Partnerships
World-Class Partnerships
Ativa develops strong partnerships with innovative biomarker developers and technology companies to create products with global impact and reach through the sales and marketing channels of our distribution partners.
As part of this, we're proud to be the exclusive global licensee of miniaturized flow cytometry technology from Honeywell International Inc., the $35 billion global leader in sensor technologies. Ativa has adopted this core technology and produced a functional prototype that is generating FDA quality results.
This technology partnership with Honeywell granted Ativa exclusive licensing rights for 60 patents.
Ativa is also exploring projects with biomarker development partners to integrate novel content with our micro-lab platform. If you're interested in learning more about the opportunities to partner with us, please contact Ativa today.

